rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2003-9-9
|
pubmed:abstractText |
The objective of this study is to assess a Simulect (basiliximab) regimen in routine clinical practice in the Spanish kidney transplantation units to evaluate efficacy and safety.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0041-1345
|
pubmed:author |
pubmed-author:BustamanteJJ,
pubmed-author:ChecaDD,
pubmed-author:Fernández RodriguezAA,
pubmed-author:FernándezCC,
pubmed-author:Gómez HuertasEE,
pubmed-author:García PérezJJ,
pubmed-author:GentilM AMA,
pubmed-author:Gomez UllatePP,
pubmed-author:LlorenteSS,
pubmed-author:Martin GovantesJ AJA,
pubmed-author:OppenheimerFF,
pubmed-author:PlazaJ JJJ,
pubmed-author:PuigJ MJM,
pubmed-author:RengerGG,
pubmed-author:Ruiz San MillánJ CJC,
pubmed-author:Sanchez GuisandeDD,
pubmed-author:Sanchez PlumedJ AJA,
pubmed-author:Sanz GuajardoAA
|
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1691-3
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12962760-Adrenal Cortex Hormones,
pubmed-meshheading:12962760-Age Factors,
pubmed-meshheading:12962760-Antibodies, Monoclonal,
pubmed-meshheading:12962760-Drug Resistance,
pubmed-meshheading:12962760-Drug Therapy, Combination,
pubmed-meshheading:12962760-Female,
pubmed-meshheading:12962760-Follow-Up Studies,
pubmed-meshheading:12962760-Graft Rejection,
pubmed-meshheading:12962760-Humans,
pubmed-meshheading:12962760-Immunosuppressive Agents,
pubmed-meshheading:12962760-Kidney Transplantation,
pubmed-meshheading:12962760-Male,
pubmed-meshheading:12962760-Middle Aged,
pubmed-meshheading:12962760-Prospective Studies,
pubmed-meshheading:12962760-Recombinant Fusion Proteins,
pubmed-meshheading:12962760-Spain,
pubmed-meshheading:12962760-Survival Analysis,
pubmed-meshheading:12962760-Time Factors
|
pubmed:year |
2003
|
pubmed:articleTitle |
Immunoprophylaxis with Simulect (basiliximab) in kidney transplantation: results from routine clinical practice at 18 kidney transplant units.
|
pubmed:affiliation |
Hospital Gregorio Marañón, Spain.
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|